PRAX - Praxis Precision Meds up 9% on new Truist buy rating
2023-09-19 12:04:29 ET
More on Praxis Precision Medicines
- Praxis Precision Medicines: Long List Of Failures And Mixed Data
- Larimar, Design higher as they benefit from Biogen deal for Reata
- Seeking Alpha’s Quant Rating on Praxis Precision Medicines
- Historical earnings data for Praxis Precision Medicines
- Financial information for Praxis Precision Medicine
For further details see:
Praxis Precision Meds up 9% on new Truist buy rating